NAT2 and tuberculosis: The NAT2 SNPs and genotype implicated as risk factors in a particular TB population may be utilized as a preemptive biomarker for stratifying the patients for more frequent serial monitoring of the LFT, particularly during the first two months of ATT, to reduce the incidence of AT-DILI.